SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001683168-22-001393
Filing Date
2022-03-03
Accepted
2022-03-02 21:28:02
Documents
1
Group Members
BRISTOL CAPITAL, LLC, PAUL L. KESSLER, DIANA DERYCZ-KESSLER

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 16 bristol_13ga16-gt.htm SC 13G/A 95564
  Complete submission text file 0001683168-22-001393.txt   97534
Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Subject) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-32837 | Film No.: 22706535
SIC: 2834 Pharmaceutical Preparations

Mailing Address 89 NEXUS WAY CAMANA BAY, PO BOX 311063 GRAND CAYMAN E9 KY1-1205
Business Address 89 NEXUS WAY CAMANA BAY, PO BOX 311063 GRAND CAYMAN E9 KY1-1205 (310) 331-8485
BRISTOL INVESTMENT FUND LTD (Filed by) CIK: 0001174866 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A